Corza Medical has announced the commercial launch of the SensorTek ROP Kit, a single-use kit that includes a diagnostic lens for performing retinopathy of prematurity (ROP) examinations. According to ...
Regeneron's EYLEA HD injection 8 mg approved by FDA for the treatment of macular edema following RVO
The US Food and Drug Administration (FDA) has approved aflibercept injection 8 mg (EYLEA HD) from Regeneron Pharmaceuticals ...
Panelists discuss how key biologic and clinical distinctions—such as ischemia, leakage patterns, and modality-specific ...
EyePoint Pharmaceuticals' DURAVYU trials for wet AMD receive positive DSMC review, highlighting safety and potential for ...
Panelists discuss how differing disease mechanisms, inflammatory drivers, and clinical priorities across AMD, DME, and RVO ...
Coave Therapeutics has announced its lead gene therapy program, CoTx-101, for the treatment of retinal vascular diseases, ...
Precise Bio has successfully treated a patient with PB-001, the company’s 3D-bio-printed corneal implant, at Rambam Medical ...
The trial is a phase 1/2 open-label, ascending-dose study of the safety and efficacy of OPGx-LCA5. Recently, the company ...
Foundation Fighting Blindness has granted public access to de-identified 4-year data from individuals participating in RUSH2A ...
Harrow has completed the acquisition of Melt Pharmaceuticals, which includes product candidates MELT-210, MELT-300, and ...
Apellis Pharmaceuticals recently announced post hoc analysis data of the GALE extension study. This new data is the result of ...
The discussion explores how basal and reflex tears differ and why composition impacts sustained eye comfort.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback